HOME >> MEDICINE >> NEWS
People Who Are Diabetic And Glucose Intolerant Can Benefit From "Statin" Drug Therapy, Even If Cholesterol Levels Are Normal

DALLAS, Dec. 8 -- A cholesterol-lowering drug may help reduce the risk of another heart attack and the need for artery-opening procedures in people with diabetes and heart disease who have average blood levels of cholesterol, according to a study in today's issue of Circulation: Journal of the American Heart Association.

The study involved a subgroup of 586 diabetic individuals in the Cholesterol and Recurrent Events (CARE) trial, a five-year study that compared therapy using the drug pravastatin to placebo in men and women who had a previous heart attack and average blood levels of cholesterol.

"Although diabetes is a major risk factor for heart disease, little information is available on the effects of cholesterol-lowering therapies in individuals with diabetes," says co-author Frank M. Sacks, M.D., associate professor of medicine at Harvard Medical School and Brigham and Women's Hospital, Boston. Because the CARE trial population -- a total of 4,159 patients from 80 clinical centers in the United States and Canada -- included a large number of individuals, scientists had enough data to determine whether pravastatin therapy reduced the risk of recurrent heart attack or the need for treatment to unblock the arteries in people with diabetes.

Pravastatin is one of the statin class of cholesterol-lowering drugs called HMG CoA inhibitors.

Sacks reports that, compared with those in the placebo group, diabetic patients who received pravastatin had a 25 percent reduction in relative risk of having another heart attack. The relative risk of needing coronary artery bypass or angioplasty to unblock blood vessels was reduced by 32 percent in the statin-treated group.

The researchers also analyzed data from a subgroup of 342 people without diabetes who met the American Diabetes Association's definition of being glucose intolerant (fasting blood glucose levels between 110 to 125 mg/dL). "This subgroup had a higher rate of coronary events, such as recu
'"/>

Contact: Carole Bullock
caroleb@heart.org
214-706-1279
American Heart Association
7-Dec-1998


Page: 1 2

Related medicine news :

1. People wounded in tsunami at risk of undetected fungal infections
2. People on food stamps cant afford heart-healthy meals
3. People are of two minds on moral judgments
4. People with low incomes more likely to develop brain tumors
5. People are averse to taking drugs
6. People with chronic eye diseases not getting recommended eye exams
7. People with large pupils can now get LASIK and avoid night vision disturbances
8. People only slightly more likely to die after episodes of stagnant air
9. People with food allergies should not only be careful about what they eat
10. People who give, live longer: U-M study shows
11. People near freeways are exposed to 30 times the concentration of dangerous particles

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/18/2018)... ... October 18, 2018 , ... Today Jon Elwell, CEO ... in healthcare, told attendees of the National Association of Long Term Hospitals ... series, you always began with the understanding that Waldo was in the picture somewhere. ...
(Date:10/17/2018)... ... ... Power to Decide, the campaign to prevent unplanned pregnancy, announced the launch ... support from the HHS Office of Adolescent Health, Innovation Next is a unique accelerator ... on technology-enabled ideas. , This year, five new teams will be selected to participate ...
(Date:10/16/2018)... ... October 16, 2018 , ... CCC ( ... midstream and downstream operators today announces Total Train Comprehensive Release version 14.1 (TTCR ... critical system components focused on improving cybersecurity defense around turbomachinery. The upgrade ...
(Date:10/16/2018)... ... October 16, 2018 , ... ... to provide simple, easy-to-use software for biopharma companies. By pairing the InTime time ... those crucial resourcing questions without spending millions of dollars implementing a complicated enterprise ...
(Date:10/16/2018)... ... October 15, 2018 , ... ... VALIDATE® Body Fluids, Order Number 205bf, for easier linearity and calibration verification. ... documentation of linearity, calibration verification and verification of the reportable range for Albumin ...
Breaking Medicine News(10 mins):
(Date:10/16/2018)... , ... October 16, 2018 , ... ... Applied Logic, the St. Louis based surgical tracking software company. Censis is the ... customers and employees to make a difference using their strong portfolio of solutions, ...
(Date:10/16/2018)... ... October 16, 2018 , ... AMGtime will be exhibiting at ... Center. At booth 1940, AMGtime will showcase time, labor management, and scheduling solutions ... their specialized Skilled Nursing Facility module . , Designed to appease common ...
(Date:10/13/2018)... (PRWEB) , ... October 13, 2018 , ... As news ... 14.4 per cent over the next five years, from $3200 million in 2017 to ... driver and could even help drive this growth further. This news comes hot on ...
Breaking Medicine Technology:
Cached News: